Restorative Proctocolectomy for Distal Ulcerative Colitis
Overview
Authors
Affiliations
Background: Chronic distal colitis may cause troublesome symptoms and alter quality of life. When medical treatment fails to control symptoms, patients and doctors are often reluctant to consider surgical resection because of the relatively small portion of the large bowel affected by the disease.
Aim: To assess the outcome of restorative proctocolectomy (RP) in patients with distal colitis who required surgery for chronic debilitating symptoms and failed medical management.
Patients/methods: From 1986 to 1996, of 263 patients receiving RP for ulcerative colitis, 27 (16 men) were operated on for distal ulcerative colitis limited to the rectum and sigmoid colon. Bowel function and quality of life were compared before and one year after RP.
Results: The mean (SD) duration of ulcerative colitis was 11 (6) years. RP was performed at a mean age of 46 (10) years. All the pouches were J-shaped, and a diverting loop ileostomy was always performed. Mean (SD) hospital stay was 25 (10) days. Seven complications occurred in six patients. Previously unknown severe dysplasia was discovered on the colectomy specimen in two patients. After RP there was a significant decrease in mean (SD) daytime stool frequency (8.2 (4) v 4.7 (2), p<0.05), night-time stool frequency (2 (2) v 1 (1), p = 0.05), and the number of patients with urgency to defecate (26/27 v 1/27, p<0.001). Sex life was improved in eight patients, social life in 26, and professional life in eight. Twenty six patients were satisfied with the results, and 25 wished that they had received surgery earlier in the course of their disease.
Conclusion: RP can improve bowel function and quality of life in patients with disabling chronic symptoms of distal ulcerative colitis.
Psychosocial factors associated with j-pouch surgery for patients with IBD: a scoping review.
Hanna Q, Tripp D, Geirc M, Gnat L, Moayyedi P, Beyak M Qual Life Res. 2023; 32(12):3309-3326.
PMID: 37347396 DOI: 10.1007/s11136-023-03454-6.
When disease extent is not always a key parameter: Management of refractory ulcerative proctitis.
Michalopoulos G, Karmiris K Curr Res Pharmacol Drug Discov. 2022; 3:100071.
PMID: 34988432 PMC: 8695253. DOI: 10.1016/j.crphar.2021.100071.
Recent advances in the management of distal ulcerative colitis.
Koutroubakis I World J Gastrointest Pharmacol Ther. 2011; 1(2):43-50.
PMID: 21577295 PMC: 3091147. DOI: 10.4292/wjgpt.v1.i2.43.
Biancone L, Calabrese E, Palmieri G, Petruzziello C, Onali S, Sica G World J Gastroenterol. 2008; 14(34):5290-300.
PMID: 18785281 PMC: 2744059. DOI: 10.3748/wjg.14.5290.
Hassan I, Horgan A, Nivatvongs S, Harrington J, Larson D J Gastrointest Surg. 2003; 7(4):567-571.
PMID: 12763418 DOI: 10.1016/S1091-255X(02)00137-3.